Leukotriene receptor antagonist therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 11085767.
- Also identified by PMC identifier 1741850.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Leukotriene receptor antagonists (LTRA) are a new class of drugs for asthma treatment, available in tablet form. Their unique mechanism of action results in a combination of both bronchodilator and anti-inflammatory effects. While their optimal place in asthma management is still under review, LTRA represent an important advance in asthma pharmacotherapy.
Medical subject headings
- Acetates
- Anti-Asthmatic Agents
- Asthma
- Leukotriene Antagonists
- Quinolines
- Tosyl Compounds